Full Press Release Details
REGENERON RECEIVES FAST-TRACK DESIGNATION FOR THE IL-1 TRAP IN CIAS 1-ASSOCIATED PERIODIC SYNDROMES (CAPS) Data from Pivotal Trial Expected in Second Half of 2006.
REGN
REGENERON RECEIVES FAST-TRACK DESIGNATION FOR THE IL-1 TRAP IN CIAS 1-ASSOCIATED PERIODIC SYNDROMES (CAPS) Data from Pivotal Trial Expected in Second Half of 2006
Key Takeaway: REGENERON RECEIVES FAST-TRACK DESIGNATION FOR THE IL-1 TRAP IN CIAS 1-ASSOCIATED PERIODIC SYNDROMES (CAPS) Data from Pivotal Trial Expected in Second Half of 2006